Sign inJoin waitlistJoin the waitlist

CH

Clifford Hudis

Physician · Memorial Hospital for Cancer and allied Diseases

Credentials: · · · ·

History

Memorial Hospital for Cancer and allied Diseases
Present

Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1986–1989
Hospital of the Medical College of Pennsylvania
1983–1986
MED COLL OF PENNSYLVANIA, PHILADELPHIA
1979–1983

Research

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
Journal of Clinical Oncology · 2016 · 2,075 citations
Trastuzumab--mechanism of action and use in clinical practice
Review · New England Journal of Medicine · 2007 · Sole author · 1,857 citations
Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive…
Journal of Clinical Oncology · 2003 · 1,171 citations

LN
Larry Norton
140 papers
Eric Winer
106 papers
AS
Andrew Seidman
57 papers
CD
Chau Dang
51 papers
AD
Andrew Dannenberg
46 papers
PM
Patrick Morris
41 papers
Harold Burstein
38 papers
Hyman Muss
35 papers
MD
Maura Dickler
34 papers
Lisa Carey
32 papers
SM
Shanu Modi
32 papers · 1 as a fellow
Hope Rugo
30 papers

Grants

Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
National Cancer Institute · U10
PI · $1.9M · Sloan-Kettering Inst Can Research
2014–2019
Cancer and Leukemia Group B
National Cancer Institute · U10
Contact PI · $2.9M · Sloan-Kettering Inst Can Research
1998–2015

Clinical trials

Lung Inflammation and Lung Metastases From Breast Cancer
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2010–2016
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery
Principal investigator · Completed · Phase 2
National Cancer Institute (NCI)
2007–2011
Doxorubicin and Cyclophosphamide Followed by Paclitaxel, Trastuzumab, and Lapatinib in Treating Patients With HER2/Neu-Overexpressed Breast Cancer
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2007–2011
Amonafide in Treating Women With Metastatic Breast Cancer That Has Progressed After Previous Chemotherapy
Principal investigator · Completed · Phase 2
Memorial Sloan Kettering Cancer Center
2003–2004